KGK Synergize


  • KGK, SourceOne Settle Litigation
    The companies settled pending litigation concerning patent rights and business practices. ...More
    January 27, 2012
    Posted in News
  • Pantesin® Lowers LDL in 16 Weeks
    A biologically active derivative of vitamin B5 (as Pantesin® from Kyowa Hakko USA), significantly lowered low-density lipoprotein (LDL) cholesterol levels in a new study that involved 120 subjects with low to moderate cardiovascular disease (CVD) risk (Nutr Res. 2011 ...More
    October 26, 2011
    Posted in News
  • KGK Synergize Donates to Vitamin Angels
    KGK Synergize Inc. launched “It Makes Cents" in support of Vitamin Angels. Effective May 1, 2011, KGK is donating a portion of every contract signed for human clinical trials to Vitamin Angels with a goal of reaching 80,000 children and mothers over the next year. ...More
    May 5, 2011
    Posted in News
  • Optimizing the Efficiencies of Clinical Efficacy Studies
    Working closely with a CRO with knowledge of the nutraceutical industry can yield optimal results for companies looking to embark on a clinical study to substantiate the safety and efficacy of a given ingredient for a given end-point. ...More
    April 21, 2011
    Posted in Articles
  • Pycnogenol® Decreases Allergy Symptoms
    A study published in the June 14, 2010 issue of Phytotherapy Research demonstrated Pycnogenol®, an antioxidant plant extract derived from the bark of the French maritime pine tree, substantially improves the symptoms of hay fever. ...More
    June 23, 2010
    Posted in News, Immune Health
  • Diabetinol™ Improves Diabetic Symptoms
    Diabetinol™, a proprietary ingredient, did not produce any adverse effects in a fructose-induced hamster model and showed improvement in blood glucose, insulin, cholesterol and triglycerides, according to a study published in the Journal of Functional Foods. ...More
    June 8, 2010
    Posted in News